The laboratory practices of Theranos, the embattled blood-testing startup led by entrepreneur Elizabeth Holmes, “pose immediate jeopardy to patient safety,” according to a letter from the U.S. Department of Health and Human Services on Monday.
The Theranos lab was surveyed by the Centers for Medicare and Medicaid Services for compliance with the Clinical Laboratory Improvement Amendments of 1988 on Nov. 20, 2015.
The lab was found deficient for hematology (the study of blood), analytic systems, and other practices.
Developing story…
This article originally appeared on Fortune.com
More Must-Reads from TIME
- How Donald Trump Won
- The Best Inventions of 2024
- Why Sleep Is the Key to Living Longer
- How to Break 8 Toxic Communication Habits
- Nicola Coughlan Bet on Herself—And Won
- What It’s Like to Have Long COVID As a Kid
- 22 Essential Works of Indigenous Cinema
- Meet TIME's Newest Class of Next Generation Leaders
Contact us at letters@time.com